Victoria Hale

Dr. Hale is the CEO and Founder of OneWorld Health, the first nonprofit pharmaceutical company in the US. Since its inception in 2000, OneWorld Health has been working to develop safe, effective, and affordable medicines for people in developing countries, and its pipeline has grown to include treatments for diseases that plague the world's poorest people, including visceral leishmaniasis, pediatric diarrhea, and malaria.

Dr. Hale was named as an Ashoka Fellow in 2006, a select group of leading social entrepreneurs who drive innovative and uncommon solutions and transformative social change work. In 2005 Dr. Hale and OneWorld Health were recognized with the Economist Innovation Award for Social and Economic Innovation, to highlight the importance of individual thinking and innovation in the business world. OneWorld Health was awarded the "Social Responsibility Award" at the 2005 Pharmaceutical Achievement Awards, and Dr. Hale and OneWorld Health were included among the Scientific American 50, the magazine's annual list recognizing outstanding acts of leadership in science and technology (2004). She was also named one of 2004's "Most Outstanding Social Entrepreneurs" by the Schwab Foundation for Social Entrepreneurship in Switzerland.

Dr. Victoria Hale established her expertise in all stages of biopharmaceutical drug development at the US Food and Drug Administration (FDA) Center for Drug Evaluation and Research and later at Genentech, Inc., the world's first biotechnology company. Dr. Hale earned her Ph.D. in Pharmaceutical Chemistry from UCSF.